We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $14.83 · 3 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Chimera (CIM) Q1 2026 Earnings Call Transcript
Chimera Investment Corp stock (US16934W1099): preferred share dividend sets tone for income-focused - AD HOC NEWS
Chimera Investment Corp stock (US16934W1099): preferred share dividend sets tone for income-focused AD HOC NEWS
Chimera Investment Corporation 8.00% Series A Cumulative Redeemable Preferred Stock (CIM/PA) - Minichart
Chimera Investment Corporation 8.00% Series A Cumulative Redeemable Preferred Stock (CIM/PA) Minichart
Chimera Investment offers a $16B mortgage REIT portfolio with strong income and moderate risk. - Pluang
Chimera Investment offers a $16B mortgage REIT portfolio with strong income and moderate risk. Pluang
How Net Losses, Dividend Coverage, and HomeXpress Growth At Chimera Investment (CIM) Has Changed Its Investment Story
Chimera Investment Q1 Earnings Call Highlights
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 05. | After market close (AMC) | $0.5 | — | — | $80.9M | — | Scheduled |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2025. 11. 19. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 07. 11. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 07. 10. | Keefe, Bruyette & Woods | — | Maintain | Market Perform → Market Perform | — | Keefe, Bruyette & Woods: Market Perform |
| 2025. 05. 14. | UBS | — | Upgrade | Neutral → Buy | — | UBS: Neutral → Buy |
| 2025. 01. 23. | JMP Securities | — | Maintain | Market Perform → Market Perform | — | JMP Securities: Market Perform |
| 2024. 08. 08. | Keefe, Bruyette & Woods | — | Maintain | Market Perform → Market Perform | — | Keefe, Bruyette & Woods: Market Perform |
As of FY2026Q1 · Source: SEC/DART + price data
No holdings data to show.